VanEck Pharmaceutical ETF Forecast

VanEck Pharmaceutical ETF downgraded from Buy Candidate to Sell Candidate after Thursday trading session.
(Updated on May 02, 2024)

PPH Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The VanEck Pharmaceutical ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance from the long-term Moving Average at $87.84. On a fall, the ETF will find some support from the short-term average at $87.11. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -0.625%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The ETF had a Golden Star Signal on Wednesday, June 14, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for VanEck Pharmaceutical ETF

VanEck Pharmaceutical finds support from accumulated volume at $87.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the ETF moved $0.780 between high and low, or 0.89%. For the last week the ETF has had daily average volatility of 0.95%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PPH) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect VanEck Pharmaceutical ETF to open at $87.57, and during the day (based on 14 day Average True Range), to move between $86.52 and $88.30, which gives a possible trading interval of +/-$0.89 (+/-1.01%) up or down from last closing price. If VanEck Pharmaceutical ETF takes out the full calculated possible swing range there will be an estimated 2.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $87.56 (0.17%) than the support at $87.13 (0.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is VanEck Pharmaceutical ETF ETF A Buy?

VanEck Pharmaceutical holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this ETF. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Sell candidate.

Current score: -1.357 Sell Candidate Downgraded

Predicted Opening Price for VanEck Pharmaceutical ETF of Friday, May 3, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.